Showing 521-530 of 2687 results for "".
Pain and Gain: Reassessing Hydrocodone Prescribing
https://practicalneurology.com/diseases-diagnoses/headache-pain/pain-and-gain-reassessing-hydrocodone-prescribing/30742/New recommendations by an FDA committee aim to decrease opioid abuse, the group says, but will physicians and patients bear the burden of its effects?Letter to the Editor: At Face Value: Obama and Neurology
https://practicalneurology.com/columns/practice-management/1109_06-php/30875/Remote Work Balances Life
https://practicalneurology.com/columns/practice-management/remote-work-balances-life/30354/Clarification of Call Coverage: Always a Duty of Neurologists
https://practicalneurology.com/columns/practice-management/PN0809_06-php/30897/New Diagnostic Tool Approved for Evaluation of Dementia Patients
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/new-diagnostic-tool-approved-for-evaluation-of-dementia-patients/30778/Amyvid, which indicates levels of beta-amyloid plaques in the brain, can help guide the diagnosis of dementia.Impaired Driving Related to Medications and Neurological Diagnoses
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/impaired-driving-related-to-medications-and-neurological-diagnoses/30686/Researchers investigated the degree to which various common agents, including benzodiazepines and non-benzodiazepine hypnotics, may affect driving ability. Therapy selection and patient counseling are key to safe use.Hometown Highlights: Congenital Myasthenic Syndromes
https://practicalneurology.com/diseases-diagnoses/neuromuscular/hometown-highlights-congenital-myasthenic-syndromes/30130/With careful diagnosis, treatment can improve symptoms of congenital myasthenic syndromes.Exploring Expanded Labeling for DBS for Parkinson's
https://practicalneurology.com/diseases-diagnoses/movement-disorders/exploring-expanded-labeling-for-dbs-for-parkinsons/30694/Expanded labeling is based on data showing an improvement in quality of life and longer-term data.Pathway to Success? MS Drug Takes Nrf-2 Pathway for Treatment
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/pathway-to-success-ms-drug-takes-nrf-2-pathway-for-treatment/30774/BG-12 is an oral therapy under regulatory review in the US and Europe for the treatment of MS.Helping Patients Navigate Barriers To Diagnostic Testing For Neurological Disorders
https://practicalneurology.com/diseases-diagnoses/imaging-testing/helping-patients-navigate-barriers-to-diagnostic-testing-for-neurological-disorders/30580/Discoveries based on the human genome have yielded greater insights about the role of genetics in disease. New diagnostic tests can help clinicians accurately diagnose a disorder and get the patient on an effective treatment plan more quickly than ever before.